Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice
about
Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Review: Complement and its regulatory proteins in kidney diseases.Physiological concentrations of soluble uric acid are chondroprotective and anti-inflammatory.Complement control protein factor H: the good, the bad, and the inadequate.Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice.Identification of a central role for complement in osteoarthritis.Inhibition of complement alternative pathway suppresses experimental autoimmune anterior uveitis by modulating T cell responsesInnate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies.Prevention of Defective Placentation and Pregnancy Loss by Blocking Innate Immune Pathways in a Syngeneic Model of Placental Insufficiency.The alternative complement pathway propagates inflammation and injury in murine ischemic strokeTargeted inhibition of complement using complement receptor 2-conjugated inhibitors attenuates EAE.Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention.Progress and Trends in Complement TherapeuticsAbrogated RANKL expression in properdin-deficient mice is associated with better outcome from collagen-antibody-induced arthritis.Essential role of surface-bound complement factor H in controlling immune complex-induced arthritisPreliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration.Complement activation and inhibition in wound healing.The complement system as a potential therapeutic target in rheumatic disease.Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage.Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.Targeted modulation of the neuroinflammatory response after spinal cord injury: the ongoing quest for the "holy grail".Macrophage-produced IL-12p70 mediates hemorrhage-induced damage in a complement-dependent manner.Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.Constitutive Activation of Integrin α9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis.Osteoarthritis and the Complement Cascade.Modulation of inflammatory arthritis by gut microbiota through mucosal inflammation and autoantibody generation.Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model.Targeting of Liver Mannan-Binding Lectin-Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis
P2860
Q33395774-71D35D11-DADE-4A6A-8974-7348ACABEF53Q33647738-713273E5-0A47-4F54-B956-5C34382B66D7Q33725818-EDC51BB3-9F5B-4D32-A53F-336CA486F62DQ34067107-2DF0D562-14F3-4AE8-9DEE-5B2403C2CE29Q34113296-94959213-C399-4582-B9FF-0344BEB2EC65Q34230334-DFBDECE7-6B09-4FBE-8B10-DDE7372F2D62Q34624453-F816274A-95FA-4D9A-9390-E295906F6118Q35194713-F0728841-BEF8-40B6-BAE0-E3F2AD62AFF1Q35864583-6F57856D-7C4F-4D06-A0CC-BC1A64601E16Q36339354-B01B9BB2-623A-40BC-93A8-70EC228723FBQ36401237-990FAC71-E780-47D6-92C7-C3FEEBD01EECQ36460034-041B6B4A-B429-4B92-B39F-A1616775368BQ36479278-DEB9BDFD-BD03-480D-9B99-0F52499BE7ADQ36633356-659140A3-884A-4E8C-9E71-6B680B57678CQ36714001-DD89CA43-587A-4E7F-8B7E-D5129DE1691CQ37361488-54661434-A519-408A-AF57-D2E4819D830DQ38076419-AD85D8C4-DEE0-4BE7-8490-401C2A73D864Q38631542-FBB158B8-E7A4-4DC4-865B-9F84B8F1A6A3Q38663694-E7614149-FECB-4B47-8F48-61F9DB82EEB0Q38879877-7A2D78A3-9C64-442D-B7F9-0A911EC9021DQ40865063-4E260987-A397-451E-B089-C700264FB3B5Q41459773-9B44C3D8-F87F-4C9D-BACE-6C95AE5C35E3Q41769162-D1C33D7C-8E5F-4506-B996-BC3198880B95Q42750928-E4A77C55-0D00-4E78-AB81-A5C77FC85E1DQ47129305-24757608-0D80-421E-B375-BF965DAA1AA0Q49709266-C8A14B1E-68E2-449E-AB36-7B454A091E9EQ51740730-799C5C76-9CF9-4E60-9032-DE1AEAB197C8Q52370705-971893FC-929D-4E6E-ABAE-EC2AD9F3B0E8Q52724247-6ED615CA-5B03-4CFF-91CC-D151B3F7D338Q58770443-5B30D444-286E-4AD2-A8E2-D3138CE023A4
P2860
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Targeted inhibition of the com ...... body-induced arthritis in mice
@ast
Targeted inhibition of the com ...... body-induced arthritis in mice
@en
type
label
Targeted inhibition of the com ...... body-induced arthritis in mice
@ast
Targeted inhibition of the com ...... body-induced arthritis in mice
@en
prefLabel
Targeted inhibition of the com ...... body-induced arthritis in mice
@ast
Targeted inhibition of the com ...... body-induced arthritis in mice
@en
P2093
P2860
P356
P1476
Targeted inhibition of the com ...... body-induced arthritis in mice
@en
P2093
Brandt Levitt
Gregory L Stahl
Joshua M Thurman
Kazue Takahashi
Magdalena J Glogowska
Nirmal K Banda
Stephen Tomlinson
V Michael Holers
William P Arend
P2860
P304
P356
10.4049/JIMMUNOL.0901826
P407
P577
2009-10-14T00:00:00Z